EU approves use of Pfizer-BioNTech vaccine in children 12 and over in Europe

EU approves use of Pfizer-BioNTech vaccine in children 12 and over in Europe

The European Commission authorised the use of the Pfizer-BioNTech vaccine in 12- to 15-year-olds on Friday, following the European Medicines Agency's approval of administering the jabs to adolescents earlier in the day.

AstraZeneca vaccine ‘safe and effective’ against Covid-19, European Medicines Agency concludes

AstraZeneca vaccine ‘safe and effective’ against Covid-19, European Medicines Agency concludes